LEO Pharma A/S, a global leader in medical dermatology and X-Chem, Inc., the global leader in DNA-encoded library (DEL) driven discovery solutions, announced today that they have entered into a research collaboration and license agreement.
HitGen announced that it has entered into a research collaboration agreement with Dorian Therapeutics, a private biotechnology company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues.